Form 483

COLONIAL DAMES CO LTD Form 483, 2023-04-12

FDA issued a Form 483 to COLONIAL DAMES CO LTD on 2023-04-12 with 6 public-safe observations.

483· Form 483 issuedHuman Drugs6 observations

COLONIAL DAMES CO LTD · Commerce, United States · Issued April 12, 2023

Overview

  • 6 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 3 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

12 Apr 2023
21 CFR 211.166(a)

Lack of written stability program

Cited by Khoa Nathan V Tran, Lillian S Wu, Rowena S Nguyen

12 Apr 2023
21 CFR 211.180(e)

Records reviewed annually

Cited by Khoa Nathan V Tran, Lillian S Wu, Rowena S Nguyen

12 Apr 2023
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Khoa Nathan V Tran, Lillian S Wu, Rowena S Nguyen

12 Apr 2023
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Khoa Nathan V Tran, Lillian S Wu, Rowena S Nguyen

12 Apr 2023
21 CFR 211.63

Equipment Design, Size and Location

Cited by Khoa Nathan V Tran, Lillian S Wu, Rowena S Nguyen

Inspected site

CDCOLONIAL DAMES CO LTDCommerce, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.180(e)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 6 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere